Jpmorgan Chase & Co »

Telomir Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.9k 2.1k 4.81
2024-03-31 $14k 2.6k 5.23

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Telomir Pharmaceuticals

BlackRock
Geode Capital Management
Suncoast Equity Management
Bank of New York Mellon
Vanguard Group
State Street Corporation
Beaird Harris Wealth Management
New York State Common Retirement Fund
Charles Schwab Investment Management
Citigroup
Morgan Stanley
Rhumbline Advisers
Bank of America Corporation
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding Telomir Pharmaceuticals